ArticleThe Journal of clinical investigation2019

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.

Bing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.